Project Grant R21AI187882
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$461K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This $382,500 five-year Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research supports research at Washington State University to study the functional and mechanistic aspects of the Lyme disease spirochete's genetic factors encoded on plasmid LP17. The key objectives are to: 1) Establish the importance of genes BBD21 and BBD22 for controlling the copy number of Borrelia burgdorferi plasmids and the...
This Project Grant award, valued at $165,000.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to develop an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the bacterium that causes Lyme disease. The project aims to create a high-efficiency transposon insertional mutagenesis system and use transposon...
The Virginia Commonwealth University was awarded a $746,009 Project Grant from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The grant falls under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research examining the cyclic-di-GMP signaling pathway and its role in the enzootic cycle of Lyme disease from November 18, 2022 through October 31, 2027. Specifically, the grant will fund...
The federal Project Grant award R01AI186279 of $1,663,244.00, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to characterize innate immune signaling pathways in the tick Ixodes scapularis. The project aims to improve understanding of immune signaling in ticks, which are vectors of Lyme and other emerging diseases, by combining cell culture-based methods with in vivo assays in...
This Project Grant award of $191,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research by Washington State University to study the mechanism of antigenic variation in the Lyme disease spirochete, Borrelia burgdorferi. The research aims to decipher the role of specific genetic factors in the expression and recombination of the VlsE surface protein, which is a key mechanism for immune...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $162,000.00 to The Johns Hopkins University to conduct research on how the spirochete Borrelia burgdorferi, the causative agent of Lyme disease, uses epidermal growth factor (EGF) as an environmental cue to coordinate its gene expression during the infection cycle. The research aims to characterize the binding of EGF...
The Project Grant award, with Federal Grant Award ID R41AI179571, is provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $300,000 award, effective July 17, 2024 through June 30, 2026, supports the development of a broad-spectrum prophylactic for tick-borne diseases, specifically Lyme disease and relapsing fever. The grantee, Planet Biotechnology Incorporated, will use a plant-based...
The University of South Florida was awarded a $509,130 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to define the role of the BosR regulator in controlling virulence gene expression and the infectious cycle of the Lyme disease pathogen Borrelia burgdorferi. Key objectives include characterizing the BosR regulon, examining the regulation of BosR expression,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $192,500.00 to the University of South Alabama to conduct research on the mechanisms of Borrelia burgdorferi central nervous system invasion in a mouse model of Lyme disease. The goal is to identify key pathways of bacterial entry into the central nervous system and associated host immune responses, which could...
The National Science Foundation (NSF) awarded a $471,214 Project Grant under the Biological Sciences (CFDA 47.074) program to the Cary Institute of Ecosystem Studies, Inc. The grant supports long-term research on the dynamics between resource pulses, rodents, ticks, and Lyme disease risk in oak forests. The key products and services to be delivered include: Collecting new data on tick numbers and survival across different life stages, integrating this into models to forecast Lyme disease risk....